Early versus late stage schizophrenia. What markers make the difference?
CONCLUSIONS: Age and IκBα are the unique markers that differentiate between ESSCH patients whose duration of illness is less than 7 years and LSSCH patients. These results support the hypothesis of toxicity of episodes and highlight the importance of preventing new episodes.
PMID: 30295120 [PubMed - as supplied by publisher]
Source: The World Journal of Biological Psychiatry - Category: Psychiatry Authors: García-Álvarez L, García-Portilla MP, Caso JR, de la Fuente-Tomás L, González-Blanco L, Sáiz Martínez P, Leza JC, Bobes J Tags: World J Biol Psychiatry Source Type: research
More News: Psychiatry | Schizophrenia | Smokers | Statistics | Students | Study | Toxicology | Universities & Medical Training